WellSpan Health is an American integrated health system headquartered in York, Pennsylvania, operating hospitals and clinics across South-Central Pennsylvania and parts of northern Maryland. While primarily a healthcare provider, WellSpan makes strategic investments in digital health and healthcare technology companies, including through its collaboration with General Catalyst.
64% of their portfolio is in Healthcare. Average disclosed round size is $90.0M (across 11 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Andrew Walker, CPA
Senior Vice President of Finance and Treasury
Cynthia Fruitrail
Executive Vice President and Chief Strategy Officer
David Gasperack, DO
Senior Vice President, WellSpan Health and Chief Medical Officer, WellSpan Medical Group
Donna Fortson
Senior Vice President and Chief Revenue Officer
Kevin L. Lewis, MD
Executive Vice President and Chief Physician Executive
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Aidoc | Series E | $150M | Jul 2025 |
 Hippocratic AI | Series B | $141M | Jan 2025 |
| HHippocratic AI, Inc. | Series B | $141M | Jan 2025 |
 Capital Rx (Judi Health) | Series F | $252M | Jan 2025 |
| Hippocratic AI | Series C | $53M | Mar 2024 |
| Hippocratic AI | Series A | $53M | Jan 2024 |
| Capital Rx (Judi Health) | Growth | $50M | Oct 2023 |
 Capital Rx | Growth | $50M | Oct 2023 |
 KeyCare | Series A | $27M | Jan 2023 |
| Aidoc | Series C | $66M | Jul 2021 |
 Babyscripts | Series B | $7.5M | — |
Top Co-Investors
Last updated: 7 October 2026